Evidence Based Approaches to Managing Hypoparathyroidism

Saturday, September 23, 2017 | Chicago Marriott Downtown Magnificent Mile 

This course is a live CME-certified ancillary symposium presented at Clinical Endocrinology Update 2017, held in Chicago, Illinois, September 23-25, 2017. CEU 2017 ancillary symposia are developed through the Endocrine Society’s Special Programs Committee (SPC).

This activity is supported by an educational grant from Shire.

John P. Bilezikian, MD, PhD (hon) - Program Director
Dorothy L. and Daniel H. Silberberg Professor of Medicine
Vice Chair, International Education and Research
Chief, Emeritus, Division of Endocrinology
College of Physicians and Surgeons, Columbia University
New York, NY

Tamara J. Vokes, MD
Professor
Section of Endocrinology, Department of Medicine
Endocrinology Fellowship Program Director 
University of Chicago, 
Chicago, IL

Learning Objectives

Upon completion of this educational activity, learners will be better able to:

  • Identify the incidence, diagnostic criteria, and clinical manifestations of hypoparathyroidism
  • Summarize conventional approaches to management with calcium, active and parent forms of vitamin D, and thiazide diuretics
  • Discuss the effects of PTH replacement therapy on long term management
  • Discuss the effects of PTH replacement on quality of life 

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Medical Knowledge
Practice-based Learning and Improvement
Systems-based Practice
Topic Area: 
Bone and Calciotropic Hormones
General Endocrinology
Thyroid/HPT Axis
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 1.00 ABIM MOC
  • 1.00 AMA PRA Category 1 Credits
  • 1.00 CME Certificate of Participation
Course opens: 
09/23/2017
Course expires: 
12/31/2017
Rating: 
5

Evidence Based Approaches to Managing Hypoparathyroidism
Saturday, September 23, 2017 | 12:15 PM – 1:15 PM

Welcome and Introduction
John P. Bilezikian, MD, PhD (hon)

Hypoparathyroidism: A Rare Disease with Major Clinical Manifestations 
John P. Bilezikian, MD, PhD (hon)

New Therapy for the Management of Hypoparathyroidism: Results of Long Term Management with PTH 
John P. Bilezikian, MD, PhD (hon)

New Therapy for the Management of Hypoparathyroidism: Results of Therapy on Quality of Live with PTH
Tamara j. Vokes, MD

Audience Q&A and Closing

Chicago Marriott Downtown Magnificent Mile
Chicago, IL
United States

John P. Bilezikian, MD, PhD (hon) - Program Director
Dorothy L. and Daniel H. Silberberg Professor of Medicine
Vice Chair, International Education and Research
Chief, Emeritus, Division of Endocrinology
College of Physicians and Surgeons, Columbia University
New York, NY

Tamara J. Vokes, MD
Professor of Medicine
Director, Osteoporosis & Metabolic Bone Disease Clinic
The University of Chicago Medicine
Chicago, IL

Disclosure Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
John P. Bilezikian: Advisor Group, Shire, Radius, Ultragenyx, Amgen; Ad Hoc Consultant: Lilly. 
Tamara J. Vokes: Advisory Board, Radius Health, Shire; Investigator, Shire.

The following SPC Committee members reported financial relationships:

Zahid Ahmad, MD: Research Support, Regeneron, FH Foundation; Consultant, Regeneron; Speaker, Amgen, Genzyme, Sanofi
Andrew Ahmann, MD: Research Support, DexCom, Lexicon, Medtronic, Novo Nordisk; Consultant, Dexcom, Novo Nordisk, Trividia Health
Giuseppe Barbesino, MD: Spouse, employee of Genzyme
John Carmichael, MD: Research Support, Novo Nordisk, Chiasma, Novartis, Pfizer, Strongbridge Biopharma; Speaker, Novartis; Advisory Board, Pfizer, Chiasma, Ionis Pharmaceuticals
Natalie Cusano, MD: Research Support, Shire; Speaker, Shire
Joan Han, MD: Research Support, Rhythm Pharmaceutical
Steven T. Harris, MD: Ad hoc consultant on Advisory Boards, Eli Lilly & Company, Merck, Radius Health; Speaker, Amgen, Eli Lilly & Company, Radius Health, Shire 
Alan Kelly, MD: Speaker, Eli Lilly
Jonathan Purnell, MD: Advisor, Novo Nordisk
Neda Rasouli, MD: Research Support, Novo Nordisk, Calibra, INTARCIA Therapeutics, GlaxoSmithKline, Bristol Meyer Squibb, AstraZeneca /Amylin, Ionis Pharmaceuticals, Boehringer Ingelheim

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships: Giuseppe Barbesino, MD;  Amy Rothberg, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

Click "Start" to complete meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The Endocrine Society has achieved Accreditation with Commendation.  The Endocrine Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™ and 1 ABIM MOC Point.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 ABIM MOC
  • 1.00 AMA PRA Category 1 Credits
  • 1.00 CME Certificate of Participation

Accreditation Period

Course opens: 
09/23/2017
Course expires: 
12/31/2017